BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, March 29, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

In the clinic for June 2, 2021

June 2, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, AC, Arthrosi, Astrazeneca, Briacell, Bridge, Calcimedica, Celltrion, Eli Lilly, Gensight, Hightide, Intensity, Janssen, Kezar, Lixte, Logicbio, Mereo, Metacrine, Pharmazz, Transcenta, Travere, Virios.
Read More

Other news to note for June 1, 2021

June 1, 2021
Alr Technologies, Altaris, Apyx Medical, Avails Medical, Brainsway, Distal Solutions, Distimp, Echosens, Excalibur Healthcare Services, Genetic Technologies, Global Healthcare SG, Gyrus Capital, Illumina, Infinity Biologics, Jiangsu Vedkang Medical Science and Technology, Kailo Medical, Livanova, Medo, Microbix Biosystems, Myriad Genetics, Next Generation Genomic, Paragon 28, Pentax Medical, Renovacare, Resonetics, Sdt Molecular, Solesis, Spineway, Zoll Medical.
Read More
Illustration of digital syringe

Vaccine vigilance in a sea of unknowns, as world limps away from COVID-19

June 1, 2021
By Karen Carey
Jam-packed with efforts to address COVID-19 variants and next-step booster shots, as well as safety concerns over vaccine co-administrations and the expansion of emergency use authorizations (EUAs) into younger populations, May was another busy pandemic-fighting month for the world, despite higher numbers of those vaccinated and declining death and hospitalization rates.
Read More
Health professional pointing stethoscope at Clinical Trial words, icons

Safety signal halts work on AB Science’s masitinib

June 1, 2021
By Richard Staines
Trading in shares in AB Science SA was suspended Tuesday after a safety signal prompted a voluntary hold on two late-stage clinical studies of its masitinib, in mastocytosis and amyotrophic lateral sclerosis, respectively.
Read More

Regulatory actions for June 1, 2021

June 1, 2021
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akebia, Alkermes, Beyondspring, Biontech, BMS, Bridgebio, CTI, Ipsen, J&J, Lannett, Mycovia, Moderna, Neuren, Neurorx, Otsuka, Paratek, Pfizer, RDIF, Respirent, Seres, Spectrum, Stallergenes.
Read More

Other news to note for June 1, 2021

June 1, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanz, Anheart, Biological, , Citrine, Defence, Diurnal, Glaxosmithkline, Hopstem, Immutep, Innovent, Lindis, Merck, Neurophth, Nexturn, NMD, Novabiotics, Polyphor, Providence, Rosvivo, Sanofi, Sutro, Vaxil.
Read More

In the clinic for June 1, 2021

June 1, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: AB, Alnylam, Annovis, Basilea, Biogen, Bio-Thera, Curevac, Dilafor, Janssen, Jasper, Liminal, Lineage, Menarini, Neuren, NH Theraguix, Nicox, Noxxon, Rhovac, Sanofi, Santhera, Tracon, Ultimovacs, Viracta.
Read More

Regulatory actions for May 28, 2021

May 28, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Guardant Health, Intelligent Implants, Thermo Fisher Scientific.
Read More
Flag of India

India does away with bridging trials for global vaccine candidates

May 28, 2021
By David Ho
HONG KONG – In the midst of a COVID-19 crisis, India has waived the need for “well-established” foreign vaccines to undergo local trials. That could open doors for vaccines by Pfizer Inc., Johnson & Johnson and Moderna Inc.
Read More

Regulatory actions for May 28, 2021

May 28, 2021
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Affamed, Amgen, Astrazeneca, Biohaven, BMS, Calliditas, Diurnal, Eton, Fennec, Humanigen, Iterum, Lantheus, Novo, PCI, Provention, Ryvu, Verrica.
Read More
Previous 1 2 … 227 228 229 230 231 232 233 234 235 … 551 552 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 27, 2026.
  • Illustration of Alzheimer's disease in the brain

    ADPD 2026: Three inflection points to target Alzheimer’s disease

    BioWorld Science
    A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
  • Art concept for Parkinson's disease

    Emerging therapeutic strategies for Parkinson’s at ADPD 2026

    BioWorld
    Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • Vials, syringes, and pills

    With improved technologies, biomarkers, failed drugs may come into their own

    BioWorld
    At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing